Four manuscripts are highlighted in the April issue of JTO. The first manuscript, “The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung” by Gazdar et al provides an excellent overview of GEMMs and is accompanied by an insightful editorial by Dr Takashi Kohno. The second article is High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma by Carbone et al. This manuscript provides useful information on this common mutation in mesothelioma. The manuscript on
ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice by Martin et al , is accompanied by an editorial by Dr Yasushi Yatabe. The last article, “Modified Masaoka Stage and Size Are Independent Prognostic Predictors in Thymoma and Modified Masaoka Stage is Superior to Histopathologic Classifications” by Roden et al addresses the issue of classification for thymoma and prognosis.
Alex A. Adjei, MD, PhD, Editor-in-Chief